What these buzzy new tests can and can't tell you.

In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or area is cancerous. However, in the U.S., between 75% and 80% of breast biopsies are benign.

Dana Friesen, CEO of Summit Sciences, brings over 15 years of experience in financial analysis and ROI optimization within the medical device sector. The firm has delivered billions in lifetime ...

Full-body MRI scans are gaining popularity, but doctors warn their benefits may not outweigh the risks for healthy, symptom-free individuals. While MRIs can detect certain cancers and abnormalities, ...

MRI is often used in the diagnostic workup ahead of breast cancer surgery, but new data from a phase 3 trial suggest the practice is unnecessary for many patients with early-stage disease. Other ...

Please provide your email address to receive an email when new articles are posted on . Preoperative breast MRI provides no benefit in stage I or II hormone receptor-negative breast cancer. Five-year ...

Patients with stage 1 or 2, hormone receptor (HR)-negative breast cancer had similar five-year rates of locoregional recurrence whether or not they underwent preoperative breast magnetic resonance ...

Editor’s Note: The publisher of the study referenced in this story has flagged the report with “expressions of concern.” This story may be updated when the journal posts further information. Women who ...

This story is sponsored by TaylorMed MRI. When you're living with chronic pain in your knees, back, shoulders, joints, or any part of your body, relief can't come soon enough. Unfortunately, dealing ...

Magnetic resonance imaging (MRI) has become an indispensable diagnostic modality in clinical medicine. Cluster-based magnetic resonance imaging contrast agents (MRICAs) demonstrate significant ...